Publication: 4412

Publication: 4412

Association of SULT2A1 with abiraterone clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer

URL

Google Scholar

Citation:

Meeting Instance:: ASHG 2024
Year:: 2024
Type:: Abstract
Sub type:: Oral/ePoster
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 4627

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Astellas
Grants:: U10CA180821, U10CA180882, U24CA196171

Corr. Author:
Authors:: Nadine Norton Nicholas B. Larson Gregory D. Jenkins Jan H. Beumer Brooke Langevin Joga Gobbaru Michael J. Morris Glenn Heller Yusuke Nakamura Michiaki Kubo Deanna Kroetz Hao-Jie Zhu Peter H. O'Donnell Lionel D. Lewis Daniel L. Hertz

Networks:: CA824, LAPS-IL057, LAPS-MD017, LAPS-MN026, LAPS-NC007, LAPS-NH012, LAPS-NY016

Study: Alliance-A031201
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Pharmacogenomics, Pharmacokinetics, SULT2A1, Expression quantitative trait loci (eQTL), Prostate cancer